PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.\', \'Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: 0015413@zju.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1043-6618(20)31235-410.1016/j.phrs.2020.104927
?:doi
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 32422341
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all